Kevin Caldwell is the founder of Ossium Health. Latest round: Series C. Backed by CPMG, Vivo Capital, First Round Capital.
Kevin Caldwell is the CEO & Co-Founder of Ossium Health, a bioengineering company focused on developing a bank of on-demand bone marrow and improving human health through bioengineering. The company has successfully raised a $52 million Series C funding round and a $63 million Series B funding round, with participation from investors like Vivo Capital and First Round Capital. Ossium Health is expanding its bone marrow bank and advancing clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library